Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia

Kidney International

Volumn 50, Issue 4, 1996, Pages 1139-1149

  Eddy, Allison A ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; HYPERCHOLESTEROLEMIA; INTERSTITIAL NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029806298     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.421     Document Type: Article

References (80)

1. VIRCHOW R: A more precise account of fatty metamorphosis, in Cellular Pathology (2nd edition), edited by CHANCE FG, England, 1860, pp 324-366
2. MOORHEAD JF, CHAN MK, EL-NAHAS M, VARGHESE Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet 2:1309-1311, 1982
3. KLAHR S, HARRIS K: Role of dietary lipids and renal eicosanoids on the progression of renal disease. Kidney Int 36(Suppl 27):S27-S31, 1989
4. MOORHEAD JF: Lipids and processive kidney disease. Kidney Int 39(Suppl 31):S35-S40, 1991
5. KEANE WF, MULCAHY WS, KASISKE BL, KIM Y, O'DONNELL MP: Hyperlipidemia and progressive renal disease. Kidney Int 39(Suppl 31):S41-S48, 1991
6. DIAMOND JR: Effect of lipid abnormalities on the progression of renal damage: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 39(Suppl 31):S29-S34, 1991
7. SCHLONDORFF D: Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 22:72-82, 1993
8. DIAMOND JR, KARNOVSKY MJ: Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation. Kidney Int 32:671-677, 1987
9. DIAMOND JR, HANCHAK NA, MCCARTER MD, KARNOVSKY MJ: Cholestyramine resin ameliorates chronic aminonucleoside nephrosis. Am J Clin Nutr 51:606-611, 1990
10. MODI KS, MORRISSEY J, SHAH SV, SCHREINER GF, KLAHR S: Effects of probucol on renal function in rats with bilateral ureteral obstruction. Kidney Int 38:843-850, 1990
11. KASISKE BL, O'DONNELL MP, GARVIS WJ, KEANE WF: Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res 62:367-374, 1988
12. MODI KS, SCHREINER GF, PURKERSON ML, KLAHR S: Effects of probucol in renal function and structure in rats with subtotal kidney ablation. J Lab Clin Med 120:310-317, 1992
13. KASISKE BL, O'DONNELL MP, CLEARY MP, KEANE WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33:667-672, 1988
14. GRÖNE H-J, WALLI A, GRÖNE E, NIEDMANN P, THIERY J, SEIDEL D, HELMCHEN U: Induction of glomeruloselerosis by dietary lipids: A functional and morphologic study in the rat. Lab Invest 60:433-446, 1989
15. KASISKE BL, O'DONNELL MP, SCHMITZ PG, KIM Y, KEANE WF: Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 37:880-891, 1990
16. AL-SHEBEB T, FROHLICH J, MAGH AB: Glomerular disease in hypercholesterolemic guinea pigs: A pathogenetic study. Kidney Int 33:498-507, 1988
17. WELLMANN KF, VOLK BW: Renal changes in experimental hypercholesterolemia in normal and in subdiabetic rabbits: II. Long-term studies. Lab Invest 24:144-155, 1971
18. PERIC-GOLIA L, PERIC-GOLIA M: Aortic and renal lesions in hypercholesterolemic adult. male, virgin Sprague-Dawley rats. Atherosclerosis 46:57-65, 1983
19. KASISKE BL, O'DONNELL MP, CLEARY MP, KEANE WF, PHILLIPS F: Effects of reduced renal mass on tissue lipids and renal injury in hyperlipidemic rats. Kidney Int 35:40-47, 1989
20. KASHYAP ML, OOI BS, HYND RA, GLUECK CJ, POLLAK VE, ROBINSON K: Sequestration and excretion of high-density and low-density lipoproteins by the kidney in human nephrotic syndrome. Artery 6:108-121, 1979
21. FROSTEGSRD J. NILSSON J, HAEGERSTRAND A, HAMSTEN A, WIGZELL H, GIDLUND M: Oxidized low-density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci USA 87:904-908, 1990
22. ROSENFELD ME, KHOO JC, MILLER E, PARTHASARATHY S, PALINSKI W. WITZTUM JL: Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest 87:90-99, 1991
23. WITZTUM JL, STELNBERG D: Role of oxidized low-density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792, 1991
24. QUINN MT, PARTHASARATHY S, FONG LG, STEINBERG D: Oxidatively modified low-density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 84:2995-2998, 1987
25. LLIIR H-A, KRÖBER M, HÜBNER C, VAJKOCZY P, MENGER MD, NOLTE D, KOHLSCHÜTTER A, MESSMER K: Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice: Involvement of CD11b/CD18 adhesion receptor complex. Lab Invest 68:388-395, 1993
26. LEHR H-A, KROMBACH F, MÜNZING S, BODLAJ R, GLAUBITT SI, SEIFFGE D, HÜBNER C, VON ANDRIAN UH, MESSMER K: In vitro effects of oxidized low-density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. Am J Pathol 146:218-227, 1995
27. KUME N, CYBULSKY MI, GIMBRONE MAJ: Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90:1138-1144, 1992
28. KHAN BV, PARTHASARAPTHY SS, ALEXANDER RW, MEDFORD RM: Modified low-density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95:1262-1270, 1995
29. YLÄ-HERTTUALA S, LIPTON BA, ROSENFELD ME, SARKIOJA T, YoSHIMURA T, LEONARD EJ. WITZTUM JL, STEINBERG D: Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88:5252-5256, 1991
30. GOLDSTEIN JL, HO YK, BASU SK, BROWN MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76:333-337, 1979
31. ONG ACM, MOORHEAD JF: Tubular lipidosis: Epiphenomenon or pathogenetic lesion in human renal disease? Kidney Int 45:753-762, 1994
32. AGARWAL A, BALLA J, CROATT A, NATH K: Oxidized LDL injuries renal tubular epithelial cells: Implications for tubulointerstitial disease. (abstract) J Am Soc Nephrol 5:935, 1994
33. KODAMA T, FREEMAN M, ROHRER L, ZABRECKY J, MATSUDAIRA P, RIEGER M: Type 1 macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 343:531-535, 1990
34. ROHRER L, FREEMAN M, KODAMA T, PENMAN M, KRIEGER M: Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 343:570-572, 1990
35. MATSUMOTO A, NAITO M, ITAKURA H, IKEMOTO S, ASAOKA H, HAYAKAWA I, KANAMORI H, ABURATANI H, TAKAKU F, SUZUKI H, KOBARI Y, MIYAL T, TAKAHASHI K, COHEN EH, WYDRO R, HOUSMAN DE, KODAMA T: Human macrophage scavenger receptors: Primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci USA 87:9133-9137, 1990
36. BICKEL PE, FREEMAN MW: Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells. J Clin Invest 90:1450-1457, 1992
37. FREEMAN M, ASHKENAS J, REES DJG, KINGSLEY DM, COPELAND NG, JENKINS NA, KRIEGER M: An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci USA 87:8810-8814, 1990
38. CLINTON SK, LIBBY P: Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med 116:1292-1300, 1992
39. LIPTAY MJ, PARKS WC, MECHAM RP, ROBY J, KAISER LR, COOPER JD, BOTNEY MD: Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J Clin Invest 91:588-594, 1993
40. OHKAWA H, OHISHI N, YAGI K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358, 1979
41. EDDY AA, MICHAEL AF: Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. Kidney Int 33:14-23, 1988
42. EDDY A: Protein restriction reduces transforming growth factor-ß and interstitial fibrosis in nephrotic syndrome. Am J Physiol 35:F884-F893, 1994
43. KIVIRIKKO KI, LAITINEN O, PROCKOP DJ: Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 19:249-255, 1967
44. EDDY AA, CRARY GS, MICHAEL AF: Identification of lymphohemopoietic cells in the kidneys of normal rats. Am J Pathol 124:335-342, 1986
45. JONES CL, BUCH S, POST M, MCCULLOCH L, LIU E, EDDY AA: The pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int 40:1020-1031, 1991
46. MAGIL AB, FROHLICH JJ, INNIS SM, STEINBRECHER UP: Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. Kidney Int 43:1243-1250, 1993
47. EDDY AA, GIACHELLI CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47:1546-1557, 1995
48. JONES CL, BUCH S, POST M, MCCULLOCH L, LIU E, EDDY AA: Renal extracellular matrix accumulation in acute purine aminonucleoside nephrosis in rats. Am J Pathol 141:1381-1396, 1992
49. CHIRGWIN JM, PRZYBYLA AE, MACDONALD RJ, RUTTER WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochem 18:5294-5299, 1979
50. NISHIDA T, HIRATO T, NISHINO N, MIZUNO K, SEKIGUCHI Y, TAKANO M, KAWAI K, NAKAI S, HIRAI Y: Cloning of the cDNAs for rat interleukin-1α and β: Monokines and other non-lymphocytic cytokines, in Progress in Leukocyte Biology (vol 8), edited by POWANDA MC, OPPENHEIM JJ, KLUGER MJ, DINARELLO CA, New York, Alan R. Liss Inc., 1988, pp 73-78
51. MERCOLA M, WANG CY, KELLY J, BROWNLEE C, JACKSON-GRUSBY L, STILES C, BOWEN-POPE D: Selective expression of PDGF A and its receptor during mouse embryogenesis. Dev Biol 138:114-122, 1990
52. MAGIL AB, COHEN AH: Monocytes and focal glomerulosclerosis. Lab Invest 61:404-409, 1989
53. KASISKE BL, O'DONNELL MP, COWARDIN W, KEANE WF: Lipids and the kidney. Hypertension 15:443-450, 1990
54. SCHÖNHOLZER KW, WALDRON M, MAGIL AB: Intraglomerular foam cells and human focal glomerulosclerosis. Nephron 62:130-136, 1992
55. KEANE WF: Lipids and the kidney. Kidney Int 46:910-920, 1994
56. GRÖNE EF, WALLI AK, GRÖNE H-J, MILLER B, SEIDEL D: The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis 107: 1-13, 1994
57. ROH DD, HA H, PAI R, IRWIN FL JR, LIM H, KIM S, KAMANNA VS, KIRSCHENBAUM MD: Effect of atherogenic lipoproteins on extracellular matrix protein expression by murine renal tubular epithelial cells. (abstract) J Am Soc Nephrol 6:908, 1995
58. HOOVER GA, MCCORMICK S, KALANT N: Interactions of native and cell-modified low-density lipoprotein with collagen gel. Arteriosclerosis 8:525-534, 1988
59. KRAEMER R, POMERANTZ KB, JOSEPH-SILVERSTEIN J, HAJJAR DP: Induction of basic fibroblast growth factor mRNA and protein synthesis in smooth muscle cells by cholesteryl ester enrichment and 25-hydroxycholesterol. J Biol Chem 268:8040-8045, 1993
60. KUME N, GIMBRONE MJ: Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 93:907-911, 1994
61. DING G, DIAMOND J: Cholesterol-supplemented diet (CSD) rapidly upregulates glomerular transforming growth factor-β1 (TGF-β1). fihronectin (FN), and type I collagen (Col I) gene expression (GE) in normal rats. (abstract) J Am Soc Nephrol 3:467, 1992
62. STUDER RK, CRAVEN PA, DERUBERTIS FR: Low-density lipoprotein stimulation of mesangial cell fihronectin synthesis: Role of protein kinase C and transforming growth factor-β. Lab Clin Med 125:86-95, 1995
63. EDDY AA: Interstitial nephritis induced by heterologous protein-overload proteinuria. Am J Pathol 135:719-733, 1989
64. SINGH RP, PATARCA R, SCHWARTZ J, SINGH P, CANTOR H: Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 171:1931-1942, 1990
65. PICHLER R, GIACHELU CM, LOMBARDI D, PIPPIN J, GORDON K, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Tubulointerstitial disease in glomerulonephritis: Potential role of osteopontin (uropontin). Am J Pathol 144:915-926, 1994
66. GIACHELLI CM, PICHLER R, LOMBARDI D, DENHARDT DT, ALPERS C, SCHWARTZ S, JOHNSON RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45:515-524, 1994
67. PICHLER RH, FRANCESCHINI N, YOUNG BA, HUGO C, ANDOH TF, BURDMANN EA, SHANKLAND SJ, ALPERS CE, BENNETT WM, COUSER WG, JOHNSON RJ: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196, 1995
68. DIAMOND JR, VAN GOOR H, DING G, ENGELMYER E: Myofibroblasts in experimental hydronephrosis. Am J Pathol 146:121-129, 1995
69. SHARMA AK, MAUER SM, KIM Y, MICHAEL AF: Interstitial fibrosis in obstructive nephropathy. Kidney Int 44:774-788, 1993
70. ENGELMYER E, VAN GOOR H, EDWARDS DR, DIAMOND JR: Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2 and -3 in experimental hydronephrosis. J Am Soc Nephrol 5:1675-1683, 1995
71. TANG WW, FENG L, XIA Y, WILSON CB: Extracellular matrix accumulation in immune-mediated tubulointerstitial injury. Kidney Int 45:1077-1084, 1994
72. YAMAMOTO T, NOBLE NA, MILLLR DE, BORDER WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
73. NAKAMURA T, EBIHARA I, SHIRATO I, TOMINO Y, KOIDE H: Increased steady-state levels of mRNA coding for extracellular matrix components in kidneys of NZB/W F1 mice. Am J Pathol 139:437-450, 1991
74. HARALAMBOUS-GASSER A, CHAN D, WALKER RG, POWELL HR, BECKER GJ, JONES CL: Collagen studies in newborn rat kidneys with incomplete ureteric obstruction. Kidney Int 44:593-605, 1993
75. TAMAKI K, OKUDA S, ANDO T, IWAMOTO T, NAKAYAMA M, FUJISHIMA M: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 45:525-536, 1994
76. WOESSNER JF JR: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154, 1991
77. EDDY A, LI Z, LIU E, MCCULLOCH L: Macrophages may mediate interstitial fibrosis via the release of transforming growth factor β1 in passive Heymann nephritis. (abstract) J Am Soc Nephrol 2:573, 1991
78. WU K, SETTY S, STASKUS K, MAUER M, ROZEN S, TSILIBARY EC: Altered matrix genes expression in experimental diabetes. (abstract) J Am Soc Nephrol 6:915, 1995
79. KRISTENSEN P, ERIKSEN J, DANO K: Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization. J Histochem Cytochem 39:341-349, 1991
80. SAPPINO A-P, HUARLE J, VASSALLI J-D, BELIN D: Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J Clin Invest 87:962-970, 1991